Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma

NCT07356245 · clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
44
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Jonathan Brammer

Collaborators